The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Skip to Page Content

Full Deal Summary

Genomics firm Pacific Biosciences of California Inc. (PacBio) netted $56.4mm through the follow-on offering of 14.1mm common shares at $4.25 each.

+ Show All | – Hide All


Click a figure for comparable deals.

Potential Deal Value $56.40mm
Transactions 1 of 1 (09/2018)
Equity $56.40mm
Total Line Value $56.40mm
Price/Share $4.25
# Shares 14.12mm
Shares Outstanding 146.01mm
Post-Money Valuation $620.53mm
Gross Proceeds $60.00mm
Net Proceeds $56.40mm

Company Information

Click a keyword for comparable companies.

Pacific Biosciences of California Inc. | Ticker: PACB
View Company Profile | View Company Deals
Company Location Worldwide
North America
Industry Biotechnology
Drug Discovery Tools
Nanotechnology, Chips, etc.
Research, Analytical Equipment & Supplies
Ownership Public
Therapeutic Area(s) of Focus Non-Specific
Alias(es) Nanofluidics Inc.
Pacific Biosciences Inc.
Company Advisors (Underwriters) Cantor Fitzgerald & Co.
Cowen & Co. LLC